Literature DB >> 17867728

The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.

Kristina Johnell1, Inga Klarin.   

Abstract

BACKGROUND: Drug-drug interactions (DDIs) are of great concern, as they are known to be related to adverse drug reactions and hospitalisations. In addition, many DDIs are regarded as predictable and avoidable; therefore, they may be considered as targets for education and interventions.
OBJECTIVE: To analyse the relationship between number of dispensed drugs and the probability of potential DDIs among the elderly by using the new Swedish Prescribed Drug Register.
METHODS: We analysed data on age, sex and dispensed drugs for people aged > or = 75 years who were registered in the Swedish Prescribed Drug Register from October to December 2005, and constructed a list of current prescriptions for every individual on the arbitrarily chosen date of 31 December 2005. Thereafter, we included those who had at least two dispensed drugs to capture the elderly population at risk of being exposed to DDIs (n = 630 743). The main outcome measures were potentially clinically relevant DDIs (type C), which may require dose adjustment, and potentially serious DDIs (type D), which should be avoided.
RESULTS: The prevalence of type C potential DDIs was 26% and of type D potential DDIs 5% in the study population. There was a strong association between number of dispensed drugs and the probability of type C potential DDIs and an even stronger association for type D potential DDIs, after adjustment for age and sex. In addition, the probability of type D potential DDIs decreased with increasing age, and women had a lower probability of type D potential DDIs than men.
CONCLUSION: There seems to be a strong relationship between number of dispensed drugs and potential DDIs, especially for potentially serious DDIs, which has implications for the importance of trying to minimise the number of drugs prescribed in the elderly. Our findings that the probability of potentially serious DDIs decreases with increasing age among the elderly and that elderly women have a lower probability of potentially serious DDIs than elderly men need to be verified and investigated by further research.

Entities:  

Mesh:

Year:  2007        PMID: 17867728     DOI: 10.2165/00002018-200730100-00009

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  33 in total

1.  Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.

Authors:  Leif I Solberg; Judith S Hurley; Melissa H Roberts; Winnie W Nelson; Floyd J Frost; A Lauren Crain; Margaret J Gunter; Linda R Young
Journal:  Am J Manag Care       Date:  2004-11       Impact factor: 2.229

2.  Multiple drug prescribing by general practitioners in a German region: Implications for drug interactions and patient safety.

Authors:  R Fux; D Greiner; M Geldmacher; K Mörike; C H Gleiter
Journal:  Int J Clin Pharmacol Ther       Date:  2006-11       Impact factor: 1.366

3.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

4.  Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.

Authors:  B Janchawee; W Wongpoowarak; T Owatranporn; V Chongsuvivatwong
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

5.  Drug interactions.

Authors:  R W Sloan
Journal:  Am Fam Physician       Date:  1983-02       Impact factor: 3.292

6.  The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old.

Authors:  Inga Klarin; Anders Wimo; Johan Fastbom
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  The consumption of drugs by 75-year-old individuals living in their own homes.

Authors:  I Barat; F Andreasen; E M Damsgaard
Journal:  Eur J Clin Pharmacol       Date:  2000-09       Impact factor: 2.953

8.  Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients.

Authors:  J Doucet; P Chassagne; C Trivalle; I Landrin; M D Pauty; N Kadri; J F Ménard; E Bercoff
Journal:  J Am Geriatr Soc       Date:  1996-08       Impact factor: 5.562

9.  Drug-related admissions to an Australian hospital.

Authors:  L A Stanton; G M Peterson; R H Rumble; G M Cooper; A E Polack
Journal:  J Clin Pharm Ther       Date:  1994-12       Impact factor: 2.512

Review 10.  Important drug-drug interactions in the elderly.

Authors:  R M Seymour; P A Routledge
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271

View more
  124 in total

1.  High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study.

Authors:  Rickard Ljung; Yunxia Lu; Jesper Lagergren
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Team Learning for Healthcare Quality Improvement.

Authors:  Narine Manukyan; Margaret J Eppstein; Jeffrey D Horbar
Journal:  IEEE Access       Date:  2013-08-28       Impact factor: 3.367

3.  Objective assessment of nonadherence and unknown co-medication in hospitalized patients.

Authors:  Florentine Carow; Karin Rieger; Ingeborg Walter-Sack; Markus R Meyer; Frank T Peters; Hans H Maurer; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2012-02-22       Impact factor: 2.953

4.  Association between multi-dose drug dispensing and drug treatment changes.

Authors:  Christina Sjöberg; Henrik Ohlsson; Susanna M Wallerstedt
Journal:  Eur J Clin Pharmacol       Date:  2012-02-04       Impact factor: 2.953

5.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

6.  Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.

Authors:  Consuelo Pedrós; Francesc Formiga; Xavier Corbella; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

Review 7.  Prevalence of statin-drug interactions in older people: a systematic review.

Authors:  Michele Thai; Emily Reeve; Sarah N Hilmer; Katie Qi; Sallie-Anne Pearson; Danijela Gnjidic
Journal:  Eur J Clin Pharmacol       Date:  2016-01-20       Impact factor: 2.953

8.  Prevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries.

Authors:  Xue Feng; Xi Tan; Brittany Riley; Tianyu Zheng; Thomas K Bias; James B Becker; Usha Sambamoorthi
Journal:  Ann Pharmacother       Date:  2017-06-21       Impact factor: 3.154

9.  Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.

Authors:  Dingwei Dai; James A Feinstein; Wynne Morrison; Athena F Zuppa; Chris Feudtner
Journal:  Pediatr Crit Care Med       Date:  2016-05       Impact factor: 3.624

Review 10.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Authors:  Kasia J Lipska; Harlan Krumholz; Tacara Soones; Sei J Lee
Journal:  JAMA       Date:  2016-03-08       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.